The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
Open accessAbstract
We monitored the antibody responses of 55 treated patients with early Lyme disease and physician-documented erythema migrans. Six sequential serum samples were obtained from patients before, during, and until one year after antibiotic therapy and analyzed by in-house enzyme-linked immunosorbent (ELISA) and immunoblot assays. An immunoblot procedure utilizing a gradient gel and an image analysis system was developed. A relational database management system was used to analyze the results and provide criteria for early disease immunoblot interpretation. Recommended criteria for the immunoglobulin M (IgM) immunoblot are the recognition of two of three proteins (24, 39, and 41 kDa). The recommended criteria for a positive IgG immunoblot are the recognition of two of five proteins (20, 24 [> 19 intensity units], 35, 39, and 88 kDa). Alternatively, if band intensity cannot be measured, the 22-kDa protein can be substituted for the 24-kDa protein with only a small decrease in sensitivity. Monoclonal antibodies were used to identify all these proteins except the 35-kDa protein. With the proposed immunoblot interpretations, the sequential serum samples were examined. At visit 1, the day of diagnosis and initiation of treatment, 54.5% of the serum samples were either IgM or IgG positive. The peak antibody response, with 80% of the serum samples positive, occurred at visit 2, 8 to 12 days into treatment. The sensitivities of the IgM and IgG immunoblot for detecting patients that were seropositive into the study period were 58.5 and 54.6%, respectively, at visit 1 and 100% at visit 2. Twenty percent of the patients remained seronegative throughout the study. The specificities of the IgM and IgG immunoblots were 92 to 94% and 93 to 96%, respectively. The IgM immunoblot and ELISA were similar in sensitivities, whereas the IgG immunoblot had greater sensitivity than the IgG ELISA (P = 0.006).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
The Spirochetal Etiology of Lyme Disease
Steere, A. C., Grodzicki, R. L., Kornblatt, A. N., Craft, J. E., Barbour, A. G., Burgdorfer, W., Schmid, G. P., Johnson, E., & Malawista, S. E. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303313081301 · Cited by 1,573
Isolation and cultivation of Lyme disease spirochetes.
Barbour, A. G. (1984) · PubMed Central · Cited by 1,556
Gel electrophoresis of proteins: a practical approach
HAMES, B. D., & RICKWOOD, D. (1981) · Cited by 1,086
Western Blotting in the Serodiagnosis of Lyme Disease
Dressler, F., Whalen, J. A., Reinhardt, B. N., & Steere, A. C. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.392 · Cited by 694
Wilske, B., Preac-Mursic, V, Jauris, S., Hofmann, A., Pradel, I., Soutschek, E., Schwab, E., Will, G., & Wanner, G. (1993) · Infection and Immunity · doi:10.1128/iai.61.5.2182-2191.1993 · Cited by 239
Lyme Disease: Recommendations for Diagnosis and Treatment
Rahn, D. W., & Malawista, S. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-6-472 · Cited by 232
Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease
Nadelman, R. B., Luger, S. W., Frank, E., Wisniewski, M., Collins, J. J., & Wormser, G. P. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-273 · Cited by 219
Shrestha, M., Grodzicki, R. L., & Steere, A. C. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90432-2 · Cited by 184
Cited by
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508667 · Cited by 2,087
Steere, A. C., Strle, F., Wormser, G. P., Hu, L. T., Branda, J. A., Hovius, J. W. R., Li, X., & Mead, P. S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.90 · Cited by 845
Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I., & Wormser, G. P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.484-509.2005 · Cited by 744
Zoonotic Potential of the Microsporidia
Mathis, A., Weber, R., & Deplazes, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.423-445.2005 · Cited by 474
Lyme Disease Testing by Large Commercial Laboratories in the United States
Hinckley, A. F., Connally, N. P., Meek, J. I., Johnson, B. J., Kemperman, M. M., Feldman, K. A., White, J. L., & Mead, P. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu397 · Cited by 386
Metadata
- Authors
- Engstrom, S. M., Shoop, E., & Johnson, R. C.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 1995-02
- Volume
- 33
- Issue
- 2
- Pages
- 419-427
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2162689245
- Cited by
- 338
- References
- 13
- FWCI
- 16.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. https://app.cochat.ai/papers/10.1128/jcm.33.2.419-427.1995
- The paper
- Engstrom, S. M., Shoop, E., & Johnson, R. C. (1995). Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.33.2.419-427.1995
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.